Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 9/20 | 0.33 |
| ▸ | HTR2A | P28223 | 7/20 | 0.33 |
| ▸ | HTR2B | P41595 | 7/20 | 0.33 |
| ▸ | HTR1A | P08908 | 6/20 | 0.33 |
| ▸ | HTR1D | P28221 | 5/20 | 0.33 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 2/20 | 0.30 |
| ▸ | BTK | Q06187 | 2/20 | 0.30 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.30 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31394467 | 0.91 | MAPK1 (0.35) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL12533487 | 0.91 | MAPK1 (0.35) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL10157275 | 0.84 | P2RX7 (0.34) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL136915 | 0.84 | P2RX7 (0.34) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL10157280 | 0.82 | P2RX7 (0.33) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL13038046 | 0.81 | — | — | |
| SCHEMBL29008843 | 0.81 | P2RX7 (0.36) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL29907038 | 0.81 | P2RX7 (0.36) | P2RX7MAPK1HTR2CHTR2AHTR2B | |
| SCHEMBL27405740 | 0.77 | P2RX7 (0.38) | P2RX7MAPK1JAK2BTK | |
| SCHEMBL10158244 | 0.77 | P2RX7 (0.35) | P2RX7MAPK1JAK2BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190284136-A1 | INDOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2019-09-19 | — | — | US | disclosed |
| US-20190284136-A1 | INDOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2019-09-19 | — | — | US | disclosed |
| US-20180334436-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2018-11-22 | — | — | US | disclosed |
| EP-3383866-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | ViiV Healthcare UK Limited (GB) | 2018-10-10 | — | — | EP | disclosed |
| EP-3016714-B1 | INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES | HIVIH (FR) | 2018-09-19 | — | — | EP | disclosed |
| US-9994509-B2 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | HIVIH (FR) | 2018-06-12 | — | — | US | disclosed |
| US-9994509-B2 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | HIVIH (FR) | 2018-06-12 | — | — | US | disclosed |
| US-9994509-B2 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | HIVIH (FR) | 2018-06-12 | — | — | US | disclosed |
| WO-2018020357-A1 | INDOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2018-02-01 | — | — | WO | disclosed |
| WO-2018020357-A1 | INDOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2018-02-01 | — | — | WO | disclosed |
| US-20100311735-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20100305115-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| US-20100305115-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| WO-2010130034-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | WO | disclosed |
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) | 2010-11-18 | — | — | US | disclosed |
| WO-2009062285-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-22 | — | — | WO | disclosed |
| WO-2009062289-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-22 | — | — | WO | disclosed |
| WO-2009062288-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-22 | — | — | WO | disclosed |
| WO-2009062308-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292227-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | RTF2, REV1, RTF1 | P2RX7 4545/4885MAPK1 1394/4885HTR2C 4360/4885 |
| US-20180334436-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | MAVS, EIF2AK2, SARS1 | P2RX7 1849/4885MAPK1 4243/4885HTR2C 637/4885 |
| US-20100305115-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | CCNY, RTF2, POLR2E | P2RX7 2690/4885MAPK1 2634/4885HTR2C 4612/4885 |
| US-20190284136-A1 | INDOLINE DERIVATIVES | IRF3, EIF2AK2, MAVS | P2RX7 1965/4885MAPK1 4499/4885HTR2C 150/4885 |
| US-20100311735-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | RTF2, REV1, POLR1E | P2RX7 4177/4885MAPK1 1742/4885HTR2C 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.